HTA logo NIHR logo
    First in class    
    9-10 October, Church House, Westminster, London    



Day One: Plenary Sessions  
Session One: Reflections on the HTA Programme and where it is today
Sir Iain Chalmers, Health Services Researcher and Coordinator of the James Lind Initiative
Session Two: International clinical effectiveness research
Dr Sean Tunis, Founder, President and CEO, Center for Medical Technology Policy, USA
Keynote speech: The role of publicly funded clinical trials
Dr Richard Horton, Editor-in-Chief, The Lancet
Keynote speech: NIHR and the HTA Programme
Professor Dame Sally C. Davies, Chief Medical Officer for England, Department of Health
Session Three: The highs and lows of doing HTA trials
Professor Freddie Hamdy, Nuffield Professor of Surgery, University of Oxford
Professor Deborah Ashby,
Chair in Medical Statistics and Clinical Trials, Imperial College London
Not available
After Dinner Speaker: Professor John Gabbay, Emeritus Professor of Public Health, University of Southampton
Day One: Parallel Sessions  
1.1 Recent results from high profile publications
Chair: Dr Peter Davidson, Director of NETSCC, HTA Programme
  • A randomised controlled trial (RCT) of alternative treatments to Inhibit VEGF in patients with Age-related choroidal Neovascularisation (IVAN)
    Professor Usha Chakravarthy, Professor of Ophthalmology and Vision Sciences, Queen's University Belfast
  • A multicentre, randomised, placebo controlled trial of lactic acid bacteria in prevention of antibiotic-associated diarrhoea (AAD) & Clostridium difficile diarrhoea (CDD) in patients aged 65 years & over admitted to hospital and receiving antibiotics (PLACIDE)
    Professor Stephen Allen, Professor of Paediatrics and International Health, Swansea University
  • Effectiveness and Cost-effectiveness of Levonorgestrel containing Intrauterine system in Primary care against Standard trEatment - The ECLIPSE Trial
    Professor Janesh Gupta, Professor of Obstetrics and Gynaecology, University of Birmingham
  • Cognitive-behavioural therapy for Health Anxiety in Medical Patients (CHAMP)
    Professor Peter Tyrer, Professor of Community Psychiatry, Imperial College London
1.2 Use of routine datasets in Health Technology Assessment
Chair: Professor Jon Deeks, Professor of Biostatistics, Director of the Birmingham Clinical Trials Unit, University of Birmingham

  • Dr Irene Petersen, Senior Research Fellow, Department of Primary Care and Population Health, University College London
  • Dr John Parkinson, Director, Clinical Practice Research Datalink (CPRD), Medicines and Health Regulatory Agency
Not available
  • Dr David Osborn, Senior Lecturer, Mental Health Sciences, University College London
1.3 What makes a successful HTA application: how to get funded and tips for success
Chair: Professor Hywel Williams, Chair of the HTA Commissioning Board and Deputy Director of the HTA, and Professor of Dermato-Epidemiology & Director of the Centre of Evidence Based Dermatology, University of Nottingham
  • Presenters:
    Ms Isabel Boyer, Public contributor for the HTA Clinical Evaluation and Trials Commissioning Board
    Professor Steven Goodacre, Professor of Emergency Medicine, University of Sheffield
1.4 What makes a successful HTA project: how to complete and deliver your project
Chair: Professor Sallie Lamb, Chair of the Clinical Evaluation and Trials Board, and Co-Director of the Oxford Clinical Trials Research Unit and Kadoorie Professor of Rehabilitation, University of Oxford
  • Professor Julia Brown, Director of Clinical Trials Research Unit, University of Leeds
  • Professor Jenny Hewison, Professor of the Psychology of Health Care, University of Leeds
  • Professor Martin Underwood, Professor of Primary Care, University of Warwick
Not available
Day Two: Plenary Sessions  
Session One: Influencing practice in the NHS
Professor Sir Mike Rawlins, President, Royal Society of Medicine
Session Two: Influence of HTA research on the academic clinical research agenda and forthcoming Research Excellence Framework (REF)
Professor Jon Nicholl, Health Services Research, School of Health and Related Research (SCHARR), University of Sheffield
Keynote speech: The value of HTA research
Lord Howe, Parliamentary Under-Secretary of State in the Department of Health
Not available
Session Three: Future direction of the HTA Programme
Professor Ian Roberts, Professor of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine
Professor Richard Lilford, Professor of Clinical Epidemiology, Vice-dean for Applied Health Research and Director of Primary Care Clinical Trials Unit, University of Birmingham
Professor Jenny Hewison, Professor of the Psychology of Health Care, University of Leeds
Dr Sean Tunis, Founder, President and CEO, Center for Medical Technology Policy, USA
Ms Isabel Boyer,
Public contributor for the HTA Clinical Evaluation and Trials Commissioning Board
Not available

Closing comments: A personal view after ten years
Professor Tom Walley CBE,
Director, NIHR Evaluation, Trials and Studies and Director of the HTA Programme

Day Two: Parallel Sessions  
2.1 Surgery
Chair: Professor Dion Morton, Director of Clinical Research, University of Birmingham
  • The place of minimal access surgery amongst people with gastro-oesophageal reflux disease - extended follow-up REFLUX-2
    Professor Craig Ramsay, Health Care Assessment Programme Director, University of Aberdeen
  • FIAT (Fistula-in-ano trial) comparing Surgisis┬« anal fistula plug versus surgeon's preference (advancement flap, fistulotomy, cutting seton) for transsphincteric fistula-in-ano
    Professor David Jayne, Senior Lecturer in Surgery, University of Leeds
2.2 Primary Care
Chair: Professor Clare Wilkinson, Professor of General Practice/Director of Research, University of Bangor
  • Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries
    Professor Simon Gates, Professor of Clinical Trials, University of Warwick
  • Randomised controlled trial of ion-exchange water softeners for the treatment of atopic eczema in children (SWET)
    Professor Kim Thomas, Associate Professor and Deputy Director Centre of Evidence Based
    Dermatology, University of Nottingham
2.3 Dementia
Chair: Professor Alistair Burns, National Clinical Director for Dementia, NHS England
  • The START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the effectiveness of a manual based coping strategy programme in promoting the mental health of carers of people with dementia
    Professor Gillian Livingston, Professor of Psychiatry of Older People, University College London
  • A pragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of Collaborative cARE for people with DEMentia in primary care (CARE-DEM trial)
    Dr Chris Fox, Clinical Senior Lecturer, University of East Anglia
2.4 Mental Health
Chair: Professor Michael King, Professor of Primary Care Psychiatry, University College London
  • Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: a randomised controlled trial (CoBaLT)
    Dr Nicola Wiles, Senior Lecturer in Epidemiology, University of Bristol
Not available
  • Antidepressant drug therapy vs a community-based psychosocial intervention for the treatment of moderate postnatal depression: a pragmatic randomised controlled trial (RESPOND)
    Professor Deborah Sharp, Professor of Primary Health Care, University of Bristol
2.5 Public Health
Chair: Professor Catherine Law, Professor of Public Health and Epidemiology, University College London
  • Double-blind, randomised, placebo-controlled trial of nicotine replacement therapy (NRT) in pregnancy (SNAP)
    Professor Tim Coleman, Professor of Primary Care, University of Nottingham
Not available
  • The clinical and cost effectiveness of exercise referral schemes: a systematic review and economic evaluation
    Professor Rod Taylor, Chair in Health Services Research, University of Exeter